Bringing the power of DNA testing to everyone.

Spartan /'sparten/ adj. & n. • adj. 1 of or relating to Sparta in ancient Greece. 2 possessing the qualities of courage, endurance, stern frugality, etc, associated with Sparta.

Spartan is a leading biotechnology company that has developed DNA analyzer the size of a coffee cup. Spartan's RX technology is cleared by the FDA and used by expert organizations such as the CDC and Mayo Clinic. Spartan's mission is making affordable products, in fields as diverse as infectious disease, precision medicine, and water safety testing.

Medical Need

In the same way that mainframe computers gave way to personal computers, high-throughput DNA testing systems in central labs are giving way to decentralized devices. Stop waiting days to weeks—get rapid results with Spartan.

Environmental Need

Bacterial culture testing with Petri dishes is technology that is 150 years old. Medical diagnostics has replaced it with fast and accurate qPCR technology. Now this trend is coming to environmental water testing. Spartan has developed the first on-site Legionella qPCR test and it enables early detection and decontamination of building water systems.

Bringing the Spartan technology to other industries

Bringing our core patented DNA technology into the hands of everyone means being open to innovation. We believe our products will rise to meet to diagnosis and detection needs beyond the clinical and environmental space.

Spartan's technology is backed by:

2 million hours of R&D

9 patents issued, 6 pending

16 peer-reviewed scientific publications

ISO 12869 validation and ISO 13485 certification

Strong group of molecular biologists and engineers

Management

Roger Eacock

Roger Eacock

Chief Executive Officer

Roger Eacock is Spartan's Chief Executive Officer. Roger is a seasoned leader with extensive experience in transformations and fast-growth companies, including TerrAscend, Sobeys, SunOpta, and Dell. Roger's broad experience in manufacturing and scaling operations globally will be critical as Spartan's moves towards the delivery execution phase of its COVID-19 test system. Roger's previous strategic turnaround leadership is the featured subject of an MBA case study at the Harvard School of Business. Roger is a member of the Royal Canadian Navy CLaS (Canadian Leaders at Sea) organization. He has also previously participated in two committees of the United Nations Global Compact, and has worked with Al Gore's Climate Reality Project since 2008.

Patrick J. Mallon

Patrick J. Mallon

Executive Director

Pat has extensive experience in the bio/pharmaceutical, medical device and life sciences industries and a successful track record in building both start-up and Fortune 500 companies. He was integral in the development and commercialization of PCR technology and introduction of the world's first protease inhibitor for HIV disease. He is a biotechnology industry leader having held leadership roles at Pfizer (NYSE: PFE), Roche (SWX: RO), and Hologic (NASDAQ: HOLX).

Paul Lem

Paul Lem, M.D.

Founder & Chief Medical Officer

As Spartan's Chief Medical Officer, Paul is responsible for the development and implementation of the company's clinical and environmental testing strategies. Paul co-founded Spartan with John Lem and Dr. Jamie Spiegelman in 2005.

Prior to Spartan, Paul served as Vice President, Product Management at DNA Genotek (acquired by Orasure Technologies). He co-invented the Oragene DNA self-collection kit that is used by millions of people around the world through companies such as 23andMe and Ancestry.com. He was also founder and CEO of Plexagen.

Paul holds a bachelor's degree in human biology from the University of Toronto, and a medical degree from the University of Ottawa. He graduated from the inaugural class of Singularity University. In 2010, Paul was honored with the $200K Premier's Catalyst Award for Best Young Innovator.

Sean Tomalty

Sean Tomalty

Chief Operating Officer

Sean joined Spartan in 2015, and is responsible for the manufacturing of Spartan's instruments and tests.

Sean has more than 30 years of experience in operations and manufacturing at companies including Abbott Point of Care, JDSU, and Nortel. At Abbott, he was Plant Director of a 500,000 square-foot medical device manufacturing facility that produced the i-STAT® portable clinical analyzer and 35 million test cartridges annually.

Sean holds a Bachelor of Mechanical Engineering degree from Carleton University and a Masters of Business Administration degree from Queen's University. He is a licensed Professional Engineer.

Trevor Brown

Trevor Brown

Chief Commercial Officer

Trevor is responsible for the overall commercial operations and strategy at Spartan, including leading commercial sales, marketing, and product strategy teams.

Trevor is an experienced commercial leader with a deep understanding of global clinical testing markets. Prior to joining Spartan, Trevor was Vice President of Precision Medicine at SeraCare Life Sciences, leading the creation and operation of a new clinical genomics business unit to access the rapidly growing genomic testing market.

Trevor holds a Master of Science (M.Sc.) in Cell Biology from the University of Alberta, and a Bachelor of Science (B.Sc.) Honors Biochemistry and Molecular Biology from McMaster University.

Steve Edgett

Steve Edgett

Executive Vice President

Steve joined Spartan in 2019 and oversees corporate strategy and international business development.

Steve has more than 15 years of experience in business development, strategic planning, and international markets such as the Middle East. He has founded and held senior leadership roles in several high-technology companies, including Knowmadics, Cobham plc, and EMS Technologies (NASDAQ: ELMG). Most recently, Steve was the CEO and President of Nautics Group, a military surveillance company.

Steve holds an honor's bachelor of applied science in systems design engineering from the University of Waterloo.

Jen Ross-Carrière

Jen Ross-Carrière

Chief Legal and Administrative Officer

Jen Ross-Carrière joined Spartan in October 2020 and is the Chief Legal & Administrative Officer. As CLAO, Jen is responsible for the legal and corporate governance of the Company as well as our People & Culture team.

With over 20 years of experience as in-house general counsel and as a lawyer at Canada's leading law firms (Gowlings WLG, Osler LLP, and McCarthy Tetrault LLP), Jen has provided legal, strategic, and operational advice to a variety of organizations in the public and private sectors including software, security, biotechnology, wireless, e-learning, telecommunications, domain name, insurance, and optical industries. She Specializes in areas such as intellectual property, licensing, contracts, corporate law, mergers & acquisitions, corporate governance, alternative dispute resolution, litigation, employment, immigration and export control.

Prior to joining Spartan, Jen was the General Counsel, Corporate Secretary, and VP, People & Culture at IFS Aviation & Defense (formerly Mxi Technologies Ltd.) where she was involved in all key legal, people, and business matters. She commenced her in-house career as General Counsel and Director of Policy for Momentous.ca Corporation, where she also assumed the role of CEO and Director of the Coalition for ICANN Transparency. Jen has appeared before the Federal Court of Canada, the Federal Court of Appeal, and before all levels of court in Ontario and has acted in various types of alternative dispute resolutions.